NIH-funded research R03 grant

Understanding how a protein affects brain function in Fragile X syndrome

Official title: Fragile X messenger ribonucleoprotein-1 mediated regulation of the Clathrin-Associated Adaptor Complex Protein-2 (AP2)

Funded at Emory University · NIH-10817391 · Data updated 2026-11-12

This study is looking at how a protein called FMRP helps control important processes in brain cells for people with Fragile X syndrome, with the hope of finding new ways to understand and address the challenges they face.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startJanuary 1, 2024
Project endDecember 31, 2025
Funding year2024
Award (this year)$156,500
NIH project number1R03MH135518-01
Project IDNIH-10817391 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Fragile X syndrome or related intellectual disabilities.

Less likely to help

Patients without Fragile X syndrome or those with other unrelated neurological conditions may not benefit from this research.

What this research studies

This research investigates the role of a specific protein, FMRP, in regulating the endocytic process, which is crucial for the proper functioning of neurons in individuals with Fragile X syndrome. By exploring how FMRP influences the surface expression of proteins involved in synaptic communication, the study aims to uncover new mechanisms that may contribute to the symptoms of Fragile X. The approach includes examining the translational regulation of proteins by FMRP, focusing on a protein complex known as AP2. This could lead to a better understanding of the molecular underpinnings of Fragile X syndrome and its associated challenges.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for improving brain function in patients with Fragile X syndrome.

How similar studies have gone: While the specific focus on FMRP's role in endocytosis is novel, related research has shown promising results in understanding the molecular mechanisms of Fragile X syndrome.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Bassell, Gary J — Emory University
  • Study coordinator: Bassell, Gary J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.